IBDEI1EV ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25021,0)
 ;;=424.0^^144^1556^6
 ;;^UTILITY(U,$J,358.3,25021,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25021,1,2,0)
 ;;=2^424.0
 ;;^UTILITY(U,$J,358.3,25021,1,5,0)
 ;;=5^MITRAL VALVE PROLAPSE
 ;;^UTILITY(U,$J,358.3,25021,2)
 ;;=^78367
 ;;^UTILITY(U,$J,358.3,25022,0)
 ;;=340.^^144^1556^7
 ;;^UTILITY(U,$J,358.3,25022,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25022,1,2,0)
 ;;=2^340.
 ;;^UTILITY(U,$J,358.3,25022,1,5,0)
 ;;=5^MULTIPLE SCLEROSIS
 ;;^UTILITY(U,$J,358.3,25022,2)
 ;;=^79761
 ;;^UTILITY(U,$J,358.3,25023,0)
 ;;=410.90^^144^1556^8
 ;;^UTILITY(U,$J,358.3,25023,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25023,1,2,0)
 ;;=2^410.90
 ;;^UTILITY(U,$J,358.3,25023,1,5,0)
 ;;=5^MYOCARDIAL INFARCTION
 ;;^UTILITY(U,$J,358.3,25023,2)
 ;;=^269673
 ;;^UTILITY(U,$J,358.3,25024,0)
 ;;=424.0^^144^1556^5
 ;;^UTILITY(U,$J,358.3,25024,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25024,1,2,0)
 ;;=2^424.0
 ;;^UTILITY(U,$J,358.3,25024,1,5,0)
 ;;=5^MITRAL STENOSIS
 ;;^UTILITY(U,$J,358.3,25024,2)
 ;;=^78367
 ;;^UTILITY(U,$J,358.3,25025,0)
 ;;=995.83^^144^1556^4
 ;;^UTILITY(U,$J,358.3,25025,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25025,1,2,0)
 ;;=2^995.83
 ;;^UTILITY(U,$J,358.3,25025,1,5,0)
 ;;=5^MILITARY SEXUAL TRAUMA
 ;;^UTILITY(U,$J,358.3,25025,2)
 ;;=^304345
 ;;^UTILITY(U,$J,358.3,25026,0)
 ;;=346.90^^144^1556^3
 ;;^UTILITY(U,$J,358.3,25026,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25026,1,2,0)
 ;;=2^346.90
 ;;^UTILITY(U,$J,358.3,25026,1,5,0)
 ;;=5^MIGRAINE,UNSPEC
 ;;^UTILITY(U,$J,358.3,25026,2)
 ;;=^336879
 ;;^UTILITY(U,$J,358.3,25027,0)
 ;;=787.01^^144^1557^1
 ;;^UTILITY(U,$J,358.3,25027,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25027,1,2,0)
 ;;=2^787.01
 ;;^UTILITY(U,$J,358.3,25027,1,5,0)
 ;;=5^NAUSEA W/ VOMITING
 ;;^UTILITY(U,$J,358.3,25027,2)
 ;;=^81644
 ;;^UTILITY(U,$J,358.3,25028,0)
 ;;=355.9^^144^1557^2
 ;;^UTILITY(U,$J,358.3,25028,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25028,1,2,0)
 ;;=2^355.9
 ;;^UTILITY(U,$J,358.3,25028,1,5,0)
 ;;=5^NEUROPATHY
 ;;^UTILITY(U,$J,358.3,25028,2)
 ;;=^78915
 ;;^UTILITY(U,$J,358.3,25029,0)
 ;;=357.2^^144^1557^3
 ;;^UTILITY(U,$J,358.3,25029,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25029,1,2,0)
 ;;=2^357.2
 ;;^UTILITY(U,$J,358.3,25029,1,5,0)
 ;;=5^NEUROPATHY,DIABETIC
 ;;^UTILITY(U,$J,358.3,25029,2)
 ;;=^96321
 ;;^UTILITY(U,$J,358.3,25030,0)
 ;;=356.9^^144^1557^4
 ;;^UTILITY(U,$J,358.3,25030,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25030,1,2,0)
 ;;=2^356.9
 ;;^UTILITY(U,$J,358.3,25030,1,5,0)
 ;;=5^NEUROPATHY,PERIPH
 ;;^UTILITY(U,$J,358.3,25030,2)
 ;;=^123931
 ;;^UTILITY(U,$J,358.3,25031,0)
 ;;=278.00^^144^1557^5
 ;;^UTILITY(U,$J,358.3,25031,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25031,1,2,0)
 ;;=2^278.00
 ;;^UTILITY(U,$J,358.3,25031,1,5,0)
 ;;=5^OBESITY, UNSP
 ;;^UTILITY(U,$J,358.3,25031,2)
 ;;=^84823
 ;;^UTILITY(U,$J,358.3,25032,0)
 ;;=278.01^^144^1557^6
 ;;^UTILITY(U,$J,358.3,25032,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25032,1,2,0)
 ;;=2^278.01
 ;;^UTILITY(U,$J,358.3,25032,1,5,0)
 ;;=5^OBESITY,MORBID
 ;;^UTILITY(U,$J,358.3,25032,2)
 ;;=^84844
 ;;^UTILITY(U,$J,358.3,25033,0)
 ;;=681.02^^144^1557^7
 ;;^UTILITY(U,$J,358.3,25033,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25033,1,2,0)
 ;;=2^681.02
 ;;^UTILITY(U,$J,358.3,25033,1,5,0)
 ;;=5^ONYCHIA OF FINGER
 ;;^UTILITY(U,$J,358.3,25033,2)
 ;;=^271884
 ;;^UTILITY(U,$J,358.3,25034,0)
 ;;=681.11^^144^1557^8
 ;;^UTILITY(U,$J,358.3,25034,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25034,1,2,0)
 ;;=2^681.11
 ;;^UTILITY(U,$J,358.3,25034,1,5,0)
 ;;=5^ONYCHIA OF TOE
 ;;^UTILITY(U,$J,358.3,25034,2)
 ;;=^271886
 ;;
 ;;$END ROU IBDEI1EV
